Prediction of presence and severity of coronary artery disease using prediction for atherosclerotic cardiovascular disease risk in China scoring system. 2021

Xu-Lin Hong, and Hao Chen, and Ya Li, and Hema Darinee Teeroovengadum, and Guo-Sheng Fu, and Wen-Bin Zhang
Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, Zhejiang Province, China.

BACKGROUND Coronary artery disease (CAD) is one of the leading causes of death and disease burden in China and worldwide. A practical and reliable prediction scoring system for CAD risk and severity evaluation is urgently needed for primary prevention. OBJECTIVE To examine whether the prediction for atherosclerotic cardiovascular disease risk in China (China-PAR) scoring system could be used for this purpose. METHODS A total of 6813 consecutive patients who underwent diagnostic coronary angiography were enrolled. The China-PAR score was calculated for each patient and CAD severity was assessed by the Gensini score (GS). RESULTS Correlation analysis demonstrated a significant relationship between China-PAR and GS (r = 0.266, P < 0.001). In receiver operating characteristic curve analysis, the cut-off values of China-PAR for predicting the presence and the severity of CAD were 7.55% with a sensitivity of 55.8% and specificity of 71.8% [area under the curve (AUC) = 0.693, 95% confidence interval: 0.681 to 0.706, P < 0.001], and 7.45% with a sensitivity of 58.8% and specificity of 67.2% (AUC = 0.680, 95% confidence interval: 0.665 to 0.694, P < 0.001), respectively. CONCLUSIONS The China-PAR scoring system may be useful in predicting the presence and severity of CAD.

UI MeSH Term Description Entries

Related Publications

Xu-Lin Hong, and Hao Chen, and Ya Li, and Hema Darinee Teeroovengadum, and Guo-Sheng Fu, and Wen-Bin Zhang
September 2022, JACC. Cardiovascular imaging,
Xu-Lin Hong, and Hao Chen, and Ya Li, and Hema Darinee Teeroovengadum, and Guo-Sheng Fu, and Wen-Bin Zhang
November 2020, European heart journal. Digital health,
Xu-Lin Hong, and Hao Chen, and Ya Li, and Hema Darinee Teeroovengadum, and Guo-Sheng Fu, and Wen-Bin Zhang
February 2016, Trends in cardiovascular medicine,
Xu-Lin Hong, and Hao Chen, and Ya Li, and Hema Darinee Teeroovengadum, and Guo-Sheng Fu, and Wen-Bin Zhang
March 2016, Current atherosclerosis reports,
Xu-Lin Hong, and Hao Chen, and Ya Li, and Hema Darinee Teeroovengadum, and Guo-Sheng Fu, and Wen-Bin Zhang
January 2017, Frontiers in cardiovascular medicine,
Xu-Lin Hong, and Hao Chen, and Ya Li, and Hema Darinee Teeroovengadum, and Guo-Sheng Fu, and Wen-Bin Zhang
August 2022, Journal of digital imaging,
Xu-Lin Hong, and Hao Chen, and Ya Li, and Hema Darinee Teeroovengadum, and Guo-Sheng Fu, and Wen-Bin Zhang
May 2008, Zhonghua yi xue za zhi,
Xu-Lin Hong, and Hao Chen, and Ya Li, and Hema Darinee Teeroovengadum, and Guo-Sheng Fu, and Wen-Bin Zhang
December 2019, American family physician,
Xu-Lin Hong, and Hao Chen, and Ya Li, and Hema Darinee Teeroovengadum, and Guo-Sheng Fu, and Wen-Bin Zhang
May 2019, JACC. Cardiovascular imaging,
Xu-Lin Hong, and Hao Chen, and Ya Li, and Hema Darinee Teeroovengadum, and Guo-Sheng Fu, and Wen-Bin Zhang
December 2011, Cardiovascular therapeutics,
Copied contents to your clipboard!